ArticleCancer2024

A phase 1 trial of 8-chloro-adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics.

Vinod Pullarkat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.